| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 5,830,537 | 108,862 | ||
| Prepaid expenses | 8,587,222 | 6,289 | ||
| Other current assets | - | 596,186 | ||
| Total current assets | 14,417,759 | 711,337 | ||
| Right-of-use asset | 60,398 | 75,837 | ||
| Total assets | 14,478,157 | 787,174 | ||
| Accrued expenses | 10,316 | 575 | ||
| Accounts payable | 114,489 | 269 | ||
| Interest payable | - | 4,447 | ||
| Lease liability, current | 61,150 | 70,636 | ||
| Total current liabilities | 185,955 | 75,927 | ||
| Lease liability, noncurrent | - | 5,816 | ||
| Loan from shareholders | - | 400,000 | ||
| Total liabilities | 185,955 | 481,743 | ||
| Common stock, 475,000,000 shares authorized 0.0001 par value 28,340,812 shares issued and outstanding as of september 30, 2025, and 24,000,000 december 31, 2024 | 2,834 | 2,400 | ||
| Preferred stock, 25,000,000 shares authorized 0.0001 par value 1,000,000 shares issued and outstanding as of september 30, 2025, and december 31, 2024 | 100 | 100 | ||
| Common stock to be issued | - | 200,000 | ||
| Additional paid-in capital | 16,063,705 | 923,309 | ||
| Accumulated deficit | -1,774,437 | -820,378 | ||
| Total shareholders equity | 14,292,202 | 305,431 | ||
| Total liabilities and shareholders equity | 14,478,157 | 787,174 | ||
Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc (CURX)